Literature DB >> 33525641

Congenital Diarrhea and Cholestatic Liver Disease: Phenotypic Spectrum Associated with MYO5B Mutations.

Denise Aldrian1, Georg F Vogel1,2, Teresa K Frey1, Hasret Ayyıldız Civan3, Aysel Ünlüsoy Aksu4, Yaron Avitzur5, Ester Ramos Boluda6, Murat Çakır7, Arzu Meltem Demir8, Caroline Deppisch9, Hans-Christoph Duba10, Gesche Düker11, Patrick Gerner12, Jozef Hertecant13, Jarmila Hornová14, Simone Kathemann15, Jutta Koeglmeier16, Arsinoi Koutroumpa17, Roland Lanzersdorfer18, Raffi Lev-Tzion19, Rosa Lima20, Sahar Mansour21, Manfred Meissl22, Jan Melek23, Mohamad Miqdady24, Jorge Hernan Montoya25, Carsten Posovszky26, Yelena Rachman19, Tania Siahanidou27, Merit Tabbers28, Holm H Uhlig29,30, Sevim Ünal31, Stefan Wirth32, Frank M Ruemmele33,34, Michael W Hess35, Lukas A Huber36,37, Thomas Müller1, Ekkehard Sturm38, Andreas R Janecke1,39.   

Abstract

Myosin Vb (MYO5B) is a motor protein that facilitates protein trafficking and recycling in polarized cells by RAB11- and RAB8-dependent mechanisms. Biallelic MYO5B mutations are identified in the majority of patients with microvillus inclusion disease (MVID). MVID is an intractable diarrhea of infantile onset with characteristic histopathologic findings that requires life-long parenteral nutrition or intestinal transplantation. A large number of such patients eventually develop cholestatic liver disease. Bi-allelic MYO5B mutations are also identified in a subset of patients with predominant early-onset cholestatic liver disease. We present here the compilation of 114 patients with disease-causing MYO5B genotypes, including 44 novel patients as well as 35 novel MYO5B mutations, and an analysis of MYO5B mutations with regard to functional consequences. Our data support the concept that (1) a complete lack of MYO5B protein or early MYO5B truncation causes predominant intestinal disease (MYO5B-MVID), (2) the expression of full-length mutant MYO5B proteins with residual function causes predominant cholestatic liver disease (MYO5B-PFIC), and (3) the expression of mutant MYO5B proteins without residual function causes both intestinal and hepatic disease (MYO5B-MIXED). Genotype-phenotype data are deposited in the existing open MYO5B database in order to improve disease diagnosis, prognosis, and genetic counseling.

Entities:  

Keywords:  MYO5B; PFIC; congenital diarrheal diseases; enteropathy; genotype–phenotype correlation; lack of protein; microvillus inclusion disease; myosin Vb; progressive familial intrahepatic cholestasis; tail domain

Year:  2021        PMID: 33525641      PMCID: PMC7865828          DOI: 10.3390/jcm10030481

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  41 in total

1.  Microvillous inclusion disease: an evolving condition.

Authors:  N M Croft; A G Howatson; S C Ling; L Nairn; T J Evans; L T Weaver
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-08       Impact factor: 2.839

2.  Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease.

Authors:  Georg F Vogel; Andreas R Janecke; Iris M Krainer; Karin Gutleben; Barbara Witting; Sally G Mitton; Sahar Mansour; Antje Ballauff; Joseph T Roland; Amy C Engevik; Ernest Cutz; Thomas Müller; James R Goldenring; Lukas A Huber; Michael W Hess
Journal:  Traffic       Date:  2017-05-17       Impact factor: 6.215

3.  Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease.

Authors:  Agata M Szperl; Magdalena R Golachowska; Marcel Bruinenberg; Rytis Prekeris; Andy-Mark W H Thunnissen; Arend Karrenbeld; Gerard Dijkstra; Dick Hoekstra; David Mercer; Janusz Ksiazyk; Cisca Wijmenga; Martin C Wapenaar; Edmond H H M Rings; Sven C D van IJzendoorn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

4.  Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity.

Authors:  L N Bull; V E Carlton; N L Stricker; S Baharloo; J A DeYoung; N B Freimer; M S Magid; E Kahn; J Markowitz; F J DiCarlo; L McLoughlin; J T Boyle; B B Dahms; P R Faught; J F Fitzgerald; D A Piccoli; C L Witzleben; N C O'Connell; K D Setchell; R M Agostini; S A Kocoshis; J Reyes; A S Knisely
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

5.  Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation.

Authors:  E Cutz; J M Rhoads; B Drumm; P M Sherman; P R Durie; G G Forstner
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

6.  Mutations in Myosin 5B in Children With Early-onset Cholestasis.

Authors:  Iram Cockar; Pierre Foskett; Sandra Strautnieks; Yasmin Clinch; Jana Fustok; Obydur Rahman; Harry Sutton; Marumbo Mtegha; Smaragdi Fessatou; Elena Kontaki; Vassiliki Papaevangelou; Maesha Deheragoda; Richard J Thompson; Tassos Grammatikopoulos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-08       Impact factor: 2.839

7.  Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.

Authors:  Rajarshi Ghosh; Ninad Oak; Sharon E Plon
Journal:  Genome Biol       Date:  2017-11-28       Impact factor: 13.583

Review 8.  MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update.

Authors:  Herschel S Dhekne; Olena Pylypenko; Arend W Overeem; Malik Zibouche; Rosaria J Ferreira; K Joeri van der Velde; Edmond H H M Rings; Carsten Posovszky; Peter van der Sluijs; Morris A Swertz; Anne Houdusse; Sven C D van IJzendoorn
Journal:  Hum Mutat       Date:  2018-01-17       Impact factor: 4.878

9.  Congenital diarrhea in a newborn infant: A case report.

Authors:  Mehrin Sadiq; Omer Choudry; Arun K Kashyap; Danitza M Velazquez
Journal:  World J Clin Pediatr       Date:  2019-08-29

10.  Cargo-selective apical exocytosis in epithelial cells is conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3.

Authors:  Georg F Vogel; Katharina M C Klee; Andreas R Janecke; Thomas Müller; Michael W Hess; Lukas A Huber
Journal:  J Cell Biol       Date:  2015-11-09       Impact factor: 10.539

View more
  5 in total

1.  UNC45A deficiency causes microvillus inclusion disease-like phenotype by impairing myosin VB-dependent apical trafficking.

Authors:  Rémi Duclaux-Loras; Corinne Lebreton; Jérémy Berthelet; Fabienne Charbit-Henrion; Ophelie Nicolle; Céline Revenu de Courtils; Stephanie Waich; Taras Valovka; Anis Khiat; Marion Rabant; Caroline Racine; Ida Chiara Guerrera; Júlia Baptista; Maxime M Mahe; Michael W Hess; Béatrice Durel; Nathalie Lefort; Céline Banal; Mélanie Parisot; Cecile Talbotec; Florence Lacaille; Emmanuelle Ecochard-Dugelay; Arzu Meltem Demir; Georg F Vogel; Laurence Faivre; Astor Rodrigues; Darren Fowler; Andreas R Janecke; Thomas Müller; Lukas A Huber; Fernando Rodrigues-Lima; Frank M Ruemmele; Holm H Uhlig; Filippo Del Bene; Grégoire Michaux; Nadine Cerf-Bensussan; Marianna Parlato
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

2.  Case Report: MYO5B Homozygous Variant c.2090+3A>T Causes Intron Retention Related to Chronic Cholestasis and Diarrhea.

Authors:  Yu Zheng; Yuming Peng; Shuju Zhang; Hongmei Zhao; Weijian Chen; Yongjia Yang; Zhengmao Hu; Qiang Yin; Yu Peng
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

3.  Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B Mutations.

Authors:  Michael W Hess; Iris M Krainer; Przemyslaw A Filipek; Barbara Witting; Karin Gutleben; Ilja Vietor; Heinz Zoller; Denise Aldrian; Ekkehard Sturm; James R Goldenring; Andreas R Janecke; Thomas Müller; Lukas A Huber; Georg F Vogel
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.964

Review 4.  Newer variants of progressive familial intrahepatic cholestasis.

Authors:  Vignesh Vinayagamoorthy; Anshu Srivastava; Moinak Sen Sarma
Journal:  World J Hepatol       Date:  2021-12-27

5.  Fetal Bowel Abnormalities Suspected by Ultrasonography in Microvillus Inclusion Disease: Prevalence and Clinical Significance.

Authors:  Yue Sun; Changsen Leng; Sven C D van Ijzendoorn
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.